Table 2.
Correlations between LCMR1 expression and clinicopathologic characteristics of human NSCLC.
| n | LCMR1 expression | P | ||
|---|---|---|---|---|
| Negative | Positive | |||
| Gender | ||||
| Male | 61 | 12 | 49 | 0.147 |
| Female | 23 | 8 | 15 | |
| Age(y) | ||||
| ≥65 | 22 | 4 | 18 | 0.471 |
| <65 | 62 | 16 | 46 | |
| Smoking status | ||||
| Yes | 45 | 10 | 35 | 0.714 |
| No | 39 | 10 | 29 | |
| Pathological type | ||||
| Adenocarcinoma | 41 | 10 | 31 | 0.614 |
| Squamous cell carcinoma | 40 | 10 | 30 | |
| Adenosquamous carcinoma | 3 | 0 | 3 | |
| Histologic grade | ||||
| PD | 28 | 6 | 22 | 0.918 |
| MD | 45 | 11 | 34 | |
| WD | 11 | 3 | 8 | |
| Lymph node metastasis | ||||
| Yes | 62 | 12 | 50 | 0.108 |
| No | 22 | 8 | 14 | |
| Clinical stage | ||||
| I-II | 40 | 14 | 26 | 0.022 |
| III-IV | 44 | 6 | 38 | |
Abbreviations: WD, well differentiated; MD, moderately differentiated; PD, poorly differentiated.